Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Instinctif Partners Public Affairs Ireland .
Filed returns
111
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to MEPs regarding a plenary debate on the associated policies of the EU Green Deal. (Public policy or programme) | 14 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to General Election Candidates regarding the key asks contained within the Medicines for Ireland manifesto. (Public policy or programme) | 114 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to relevant political representatives in light of Government Formation talks. (Public policy or programme) | 21 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to the Minister for Health, Stephen Donnelly TD, regarding the Bolar clause of the EU Pharmaceutical Legislation. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to Robert Watt regarding the implications of the Urban Waste Water Treatment Directive for the biosimilar, generic and off-patent medicines industry. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to Niall Redmond regarding the arrangement of an in-person meeting. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to Stephen Donnelly TD, regarding the omittance of generic, biosimilar and value-added medicines in the Fianna Fáil General Election Manifesto. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to Minister Darragh O'Brien TD, seeking a meeting to discuss the implementation of the Urban Waste Water Treatment Directive. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Meeting with MEP Barry Andrews regarding areas of interest for Medicines for Ireland and its members. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Meeting with MEP Billy Kelleher regarding areas of interest for Medicines for Ireland and its members. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to political stakeholders regarding MFI's General Election Manifesto. (Public policy or programme) | 14 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to political representatives regarding the implications of the Urban Waste Water Treatment Directive for the biosimilar, generic and off-patent medicines industry. (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to Irish MEPs congratulating them on their election to the European Parliament. (Public policy or programme) | 14 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Discuss the EU pharmaceutical directive (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Discuss the Urban Wastewater Treatment Directive (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Discuss coordination of national stockpiling measures to prevent medicine shortages. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Discuss the Health (Miscellaneous Provisions) Bill 2024 (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Follow up to the annual Medicines for Europe 2024 conference 12-13 June in Dublin (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Discuss Per- and polyfluoroalkyl substances (PFAS) chemicals and the impact on the generic, biosimilar and value added medicines industry. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Meeting request regarding the unified position taken by the HSE placing an across-the-board price freeze on all regulated and non-regulated goods and services without giving due consideration to the impact this will… (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Invitation to the Medicines for Europe 18th Legal Affairs Conference 10-11 June in Dublin (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Invitation to the annual Medicines for Europe 2024 conference: 12 - 13 June in Dublin (Public policy or programme) | 22 | On lobbying.ie |
| Jan–Apr 2024 | Instinctif Partners Public Affairs Ireland | Health | Communication regarding strengthening legal certainty and healthy competition through a clear ban of unlawful practices in the revision of EU Pharmacetuical Legislation (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2024 | Instinctif Partners Public Affairs Ireland | Health | Communication regarding Minister Donnelly's available to provide an opening address to the annual Medicines for Europe 2024 conference - 12 - 13 June in Dublin (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Instinctif Partners Public Affairs Ireland | Health | Invitation to provide an address at the annual Medicines for Europe 2024 conference - 12 - 13 June in Dublin (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2024 | Instinctif Partners Public Affairs Ireland | Health | Communication regarding medicine repurposing as part of the revision of EU Pharmaceutical Legislation (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2024 | Instinctif Partners Public Affairs Ireland | Health | Communication regarding engagement with the Department of Health Taskforce on Productivity and Savings (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2023 | Instinctif Partners Public Affairs Ireland | Health | To discuss the EU Pharma Package (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | Instinctif Partners Public Affairs Ireland | Health | Discuss EU legislative activities and the impact on the generics and biosimilar medicines (Public policy or programme) | 14 | On lobbying.ie |
| Sep–Dec 2023 | Instinctif Partners Public Affairs Ireland | Health | To discuss the MFI pre-budget submission 2024 (Public policy or programme) | 28 | On lobbying.ie |
| May–Aug 2023 | Instinctif Partners Public Affairs Ireland | Health | Engagement with EU policy makers regarding the Urban Wastewater Treatment Directive (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2023 | Instinctif Partners Public Affairs Ireland | Health | Engagement with Irish and EU policy makers regarding EU regulation affecting pressurised Metered Dose Inhalers (pMDIs) (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2023 | Instinctif Partners Public Affairs Ireland | Health | Shared Medicines for Europe letter to key EU figures ahead of EPSCO meeting on Health (14th March) (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Instinctif Partners Public Affairs Ireland | Health | Engagment with the Department with respect to the review of goverance of drug reimbursement processes and recommendations set out in the Mazars Report (published 24/02/23). (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2023 | Instinctif Partners Public Affairs Ireland | Health | Engagement with the Department of Health regarding the review of governance arrangements to support HSE drug reimbursement process (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2023 | Instinctif Partners Public Affairs Ireland | Health | Notification of MFI lessons learned from Covid-19 Report in the context of upcoming Government inquiry into Covid-19, in order to raise awareness of medicines shortages in Ireland and the sustainable supply of medicines… (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2023 | Instinctif Partners Public Affairs Ireland | Health | Engagement with Irish and EU policy makers regarding EU regulation affecting pressurised Metered Dose Inhalers (pMDIs) (Public policy or programme) | 34 | On lobbying.ie |
| Sep–Dec 2022 | Instinctif Partners Public Affairs Ireland | Health | Engagement with Duncan Smith TD regarding Parliamentary Questions submitted on medicine shortages and generic medicine use in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2022 | Instinctif Partners Public Affairs Ireland | Health | Engagement with members of the Oireachtas Health Committee in order to raise awareness of medicines shortages in Ireland and the sustainable supply of medicines in Ireland (Public policy or programme) | 12 | On lobbying.ie |
| Sep–Dec 2022 | Instinctif Partners Public Affairs Ireland | Health | Engagement with Colm Burke TD regarding MFI 2023 Pre Budget Submission in order to raise awareness of medicines shortages in Ireland and the sustainable supply of medicines in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2022 | Instinctif Partners Public Affairs Ireland | Health | Engagement with the Department of Health in order to raise awareness of medicines shortages in Ireland and the sustainable supply of medicines in Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2022 | Instinctif Partners Public Affairs Ireland | Health | Notification of MFI 2023 Pre Budget Submission to all members of the Oireachtas Health Committee and relevant Ministers in order to raise awareness of medicines shortages in Ireland and the sustainable supply of… (Public policy or programme) | 17 | On lobbying.ie |
| May–Aug 2022 | Instinctif Partners Public Affairs Ireland | Health | Letter from Medicines for Ireland (MFI) Chairperson, Padraic O’Brien, along with a copy of the MFI ‘Generic Medicine Usage in Ireland’ infographic (Public policy or programme) | 0 | On lobbying.ie |
| May–Aug 2022 | Instinctif Partners Public Affairs Ireland | Health | Letter from Medicines for Ireland (MFI) Chairperson Padraic O'Brien to Minister for EU Affairs, Thomas Byrne TD (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2022 | Instinctif Partners Public Affairs Ireland | Health | Email to Denis Naughten TD regarding PQ on generic medicines usage in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2022 | Instinctif Partners Public Affairs Ireland | Health | Virtual Event for Generic Medicines Day hosted by Medicines for Ireland (Public policy or programme) | 0 | On lobbying.ie |
| May–Aug 2022 | Instinctif Partners Public Affairs Ireland | Health | Invitation to participate as guest speaker at Medicines for Ireland (MFI) Generics Day virtual event (16th of June 2022) (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2022 | Instinctif Partners Public Affairs Ireland | Health | MFI report -Value Added Medicines: Advancing Medicines Repurposing in the EU and cover letter (Public policy or programme) | 0 | On lobbying.ie |
| Jan–Apr 2022 | Instinctif Partners Public Affairs Ireland | Health | Discussions in relation to the use of generic and biosmilar medicines in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2021 | Instinctif Partners Public Affairs Ireland | Health | Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2021 (Public policy or programme) | 0 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 111 | 100.0% |